Drug development of an affinity enhanced, broadly neutralizing heavy chain-only antibody that restricts SARS-CoV-2 in rodentsBert Schepens,Loes van Schie,Wim Nerinckx,Kenny Roose,Wander Van Breedam,Daria Fijalkowska,Simon Devos,Wannes Weyts,Sieglinde De Cae,Sandrine Vanmarcke,Chiara Lonigro,Hannah Eeckhaut,Dries Van Herpe,Jimmy Borloo, Ana Filipa Oliveira,Joao Paulo Catani,Sarah Creytens,Dorien De Vlieger,Gitte Michielsen,Jackeline Cecilia Zavala Marchan,George D. Moschonas,Iebe Rossey,Koen Sedeyn,Annelies Van Hecke,Xin Zhang,Lana Langendries,Sofie Jacobs,Sebastiaan ter Horst,Laura Seldeslachts,Laurens Liesenborghs,Robbert Boudewijns,Hendrik Jan Thibaut,Kai Dallmeier,Greetje Vande Velde,Birgit Weynand,Julius Beer,Daniel Schnepf,Annette Ohnemus,Isabel Remory,Caroline S. Foo,Rana Abdelnabi,Piet Maes,Suzanne J. F. Kaptein,Joana Rocha-Pereira,Dirk Jochmans,Leen Delang,Frank Peelman,Peter Staeheli,Martin Schwemmle,Nick Devoogdt,Dominique Tersago,Massimiliano Germani,James Heads,Alistair Henry,Andrew Popplewell,Mark Ellis,Kevin Brady,Alison Turner,Bruno Dombrecht,Catelijne Stortelers,Johan Neyts,Nico Callewaert,Xavier SaelensbioRxiv（2021）引用 5|浏览38关键词antibody,chain-only,sars-covAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
